XML 48 R37.htm IDEA: XBRL DOCUMENT
v3.26.1

Reportable Segments (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2026
Segment Reporting [Abstract] |
Schedule of Reportable Segment Financial Information | The Company identifies its operating segments for segment reporting purposes primarily on the basis of product type, production processes, distribution methods and management organizations. Reportable Segment Financial Information (in thousands):
| Three Months Ended June 30, 2026
| EMG |  | EIG |  | Corporate |  | Total Consolidated
Net Sales | $ | 723,244 |  |  | $ | 1,321,153 |  |  | $ | — |  |  | $ | 2,044,397 |
Cost of sales (1) | 509,125 |  |  | 800,231 |  |  | — |  |  | 1,309,356 |
Selling expense | 24,802 |  |  | 151,200 |  |  | — |  |  | 176,002 |
Segment Operating Income | 189,317 |  |  | 369,722 |  |  | — |  |  | 559,039 |
Corporate G&A | — |  |  | — |  |  | 30,846 |  |  | 30,846 |
Operating Income | 189,317 |  |  | 369,722 |  |  | (30,846) |  |  | 528,193 |
Interest expense (2) | — |  |  | — |  |  | (30,101) |  |  | (30,101) |
Other (expense) income, net | — |  |  | — |  |  | (5,720) |  |  | (5,720) |
Income before Income Taxes | $ | 189,317 |  |  | $ | 369,722 |  |  | $ | (66,667) |  |  | $ | 492,372 |
Depreciation | 15,732 |  |  | 19,417 |  |  | 1,655 |  |  | 36,804 |
Amortization | 18,811 |  |  | 50,316 |  |  | — |  |  | 69,127 |
Total depreciation and amortization | $ | 34,543 |  |  | $ | 69,733 |  |  | $ | 1,655 |  |  | $ | 105,931 |
Research, Development & Engineering costs (3) | $ | 22,099 |  |  | $ | 88,822 |  |  | $ | — |  |  | $ | 110,921 |
Assets | $ | 5,119,728 |  |  | $ | 10,684,591 |  |  | $ | 790,394 |  |  | $ | 16,594,713 |
Capital Expenditures | $ | 10,908 |  |  | $ | 15,675 |  |  | $ | 5,428 |  |  | $ | 32,011 |
(1)Includes $16.2 million of acquisition-related costs. (2)Includes $10.0 million of acquisition-related financing fees. (3)Included in cost of sales.
| Three Months Ended June 30, 2025
| EMG |  | EIG |  | Corporate |  | Total Consolidated
Net Sales | $ | 618,485 |  |  | $ | 1,159,571 |  |  | $ | — |  |  | $ | 1,778,056 |
Cost of sales | 452,132 |  |  | 690,035 |  |  | — |  |  | 1,142,167 |
Selling expense | 22,465 |  |  | 125,108 |  |  | — |  |  | 147,573 |
Segment Operating Income | 143,888 |  |  | 344,428 |  |  | — |  |  | 488,316 |
Corporate G&A | — |  |  | — |  |  | 26,690 |  |  | 26,690 |
Operating Income | 143,888 |  |  | 344,428 |  |  | (26,690) |  |  | 461,626 |
Interest expense | — |  |  | — |  |  | (16,857) |  |  | (16,857) |
Other (expense) income, net | — |  |  | — |  |  | (2,600) |  |  | (2,600) |
Income before Income Taxes | $ | 143,888 |  |  | $ | 344,428 |  |  | $ | (46,147) |  |  | $ | 442,169 |
Depreciation | $ | 15,665 |  |  | $ | 19,130 |  |  | $ | 1,481 |  |  | $ | 36,276 |
Amortization | 26,812 |  |  | 44,613 |  |  | — |  |  | 71,425 |
Total depreciation and amortization | $ | 42,477 |  |  | $ | 63,743 |  |  | $ | 1,481 |  |  | $ | 107,701 |
Research, Development & Engineering costs (1) | $ | 21,032 |  |  | $ | 73,195 |  |  | $ | — |  |  | $ | 94,227 |
Assets | $ | 4,847,262 |  |  | $ | 9,541,110 |  |  | $ | 878,174 |  |  | $ | 15,266,546 |
Capital Expenditures | $ | 10,193 |  |  | $ | 11,266 |  |  | $ | 7,810 |  |  | $ | 29,269 |
(1)Included in cost of sales.
| Six Months Ended June 30, 2026
| EMG |  | EIG |  | Corporate |  | Total Consolidated
Net Sales | $ | 1,387,145 |  |  | $ | 2,585,689 |  |  | $ | — |  |  | $ | 3,972,834 |
Cost of sales (1) | 979,217 |  |  | 1,541,017 |  |  | — |  |  | 2,520,234 |
Selling expense | 47,845 |  |  | 301,012 |  |  | — |  |  | 348,857 |
Segment Operating Income | 360,083 |  |  | 743,660 |  |  | — |  |  | 1,103,743 |
Corporate G&A | — |  |  | — |  |  | 60,614 |  |  | 60,614 |
Operating Income | 360,083 |  |  | 743,660 |  |  | (60,614) |  |  | 1,043,129 |
Interest expense (2) | — |  |  | — |  |  | (51,010) |  |  | (51,010) |
Other (expense) income, net | — |  |  | — |  |  | (6,767) |  |  | (6,767) |
Income before Income Taxes | $ | 360,083 |  |  | $ | 743,660 |  |  | $ | (118,391) |  |  | $ | 985,352 |
Depreciation | $ | 31,178 |  |  | $ | 38,595 |  |  | $ | 3,292 |  |  | $ | 73,065 |
Amortization | 37,214 |  |  | 101,142 |  |  | — |  |  | 138,356 |
Total depreciation and amortization | $ | 68,392 |  |  | $ | 139,737 |  |  | $ | 3,292 |  |  | $ | 211,421 |
Research, Development & Engineering costs (3) | $ | 44,630 |  |  | $ | 177,867 |  |  | $ | — |  |  | $ | 222,497 |
Capital Expenditures | $ | 20,252 |  |  | $ | 28,516 |  |  | $ | 8,711 |  |  | $ | 57,479 |
(1)Includes $17.8 million of acquisition-related costs. (2)Includes $10.0 million of acquisition-related financing fees. (3)Included in cost of sales.
| Six Months Ended June 30, 2025
| EMG |  | EIG |  | Corporate |  | Total Consolidated
Net Sales | $ | 1,206,783 |  |  | $ | 2,303,244 |  |  | $ | — |  |  | $ | 3,510,027 |
Cost of sales | 889,920 |  |  | 1,359,218 |  |  | — |  |  | 2,249,138 |
Selling expense | 44,257 |  |  | 245,548 |  |  | — |  |  | 289,805 |
Segment Operating Income | 272,606 |  |  | 698,478 |  |  | — |  |  | 971,084 |
Corporate G&A | — |  |  | — |  |  | 54,629 |  |  | 54,629 |
Operating Income | 272,606 |  |  | 698,478 |  |  | (54,629) |  |  | 916,455 |
Interest expense | — |  |  | — |  |  | (35,850) |  |  | (35,850) |
Other (expense) income, net | — |  |  | — |  |  | (4,214) |  |  | (4,214) |
Income before Income Taxes | $ | 272,606 |  |  | $ | 698,478 |  |  | $ | (94,693) |  |  | $ | 876,391 |
Depreciation | $ | 31,058 |  |  | $ | 37,887 |  |  | $ | 2,917 |  |  | $ | 71,862 |
Amortization | 53,455 |  |  | 88,751 |  |  | — |  |  | 142,206 |
Total depreciation and amortization | $ | 84,513 |  |  | $ | 126,638 |  |  | $ | 2,917 |  |  | $ | 214,068 |
Research, Development & Engineering costs (1) | $ | 42,275 |  |  | $ | 146,817 |  |  | $ | — |  |  | $ | 189,092 |
Capital Expenditures | $ | 17,357 |  |  | $ | 21,669 |  |  | $ | 13,312 |  |  | $ | 52,338 |
(1)Included in cost of sales.

X
- Definition Tabular disclosure of segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26A Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration